Terms: = Lymphoma AND RUNX1, PEBP2A2, 861, ENSG00000159216, Q01196, AML1, CBFA2, AMLCR1 AND Treatment
310 results:
1. [Use of the ETV6/runx1 probe to verify the performance of the fluorescence in situ hybridization probe before clinical detection].
Xiao J; Zheng YC; Zhao JW; Cui CH; Wang HJ; Sun Q; Ma J; Ma YS; Song Z; Xiao ZJ; Li CW
Zhonghua Xue Ye Xue Za Zhi; 2024 Jan; 45(1):48-53. PubMed ID: 38527838
[No Abstract] [Full Text] [Related]
2. [Multicenter evaluation of minimal residual disease monitoring in early induction therapy for treatment of childhood acute lymphoblastic leukemia].
Wu XJ; Liao N; Mai HR; Li XY; Wan WQ; Yang LH; Huang LB; Luo XQ; Tian C; Chen QW; Long XJ; He YY; Wang Y; Li ZG; Xu HG
Zhonghua Er Ke Za Zhi; 2024 Mar; 62(4):337-344. PubMed ID: 38527504
[No Abstract] [Full Text] [Related]
3. Epidemiology and risk factors of bloodstream infections among adolescents and young adults with acute lymphoblastic leukaemia: An 11-year retrospective cohort study.
Xue L; Tang Y; Wang L; Xu C; Cheng Q; Li X
Clin Exp Pharmacol Physiol; 2024 Apr; 51(4):e13850. PubMed ID: 38452755
[TBL] [Abstract] [Full Text] [Related]
4. [Clinical features and prognostic analysis of testicular relapse in pediatric acute lymphoblastic leukemia].
Wang N; Gao YY; Qi BQ; Ruan M; Lyu H; Zhang XY; Zhang RR; Liu TF; Chen YM; Zou Y; Guo Y; Yang WY; Zhang L; Zhu XF; Chen XJ
Zhonghua Er Ke Za Zhi; 2024 Mar; 62(3):262-267. PubMed ID: 38378289
[No Abstract] [Full Text] [Related]
5. CD371-positive pediatric B-cell acute lymphoblastic leukemia: propensity to lineage switch and slow early response to treatment.
Buldini B; Varotto E; Maurer-Granofszky M; Gaipa G; Schumich A; Brüggemann M; Mejstrikova E; Cazzaniga G; Hrusak O; Szczepanowski M; Scarparo P; Zimmermann M; Strehl S; Schinnerl D; Zaliova M; Karawajew L; Bourquin JP; Feuerstein T; Cario G; Alten J; Möricke A; Biffi A; Parasole R; Fagioli F; Valsecchi MG; Biondi A; Locatelli F; Attarbaschi A; Schrappe M; Conter V; Basso G; Dworzak MN
Blood; 2024 Apr; 143(17):1738-1751. PubMed ID: 38215390
[TBL] [Abstract] [Full Text] [Related]
6. MYCT1 inhibits hematopoiesis in diffuse large B-cell lymphoma by suppressing runx1 transcription.
Liang Y; Wei X; Yue PJ; Zhang HC; Li ZN; Wang XX; Sun YY; Fu WN
Cell Mol Biol Lett; 2024 Jan; 29(1):5. PubMed ID: 38172714
[TBL] [Abstract] [Full Text] [Related]
7. Donor-Derived Malignancy and Transplantation Morbidity: Risks of Patient and Donor Genetics in Allogeneic Hematopoietic Stem Cell Transplantation.
Williams LS; Williams KM; Gillis N; Bolton K; Damm F; Deuitch NT; Farhadfar N; Gergis U; Keel SB; Michelis FV; Panch SR; Porter CC; Sucheston-Campbell L; Tamari R; Stefanski HE; Godley LA; Lai C
Transplant Cell Ther; 2024 Mar; 30(3):255-267. PubMed ID: 37913908
[TBL] [Abstract] [Full Text] [Related]
8. A surrogate molecular approach for the detection of Philadelphia chromosome-like B-acute lymphoblastic leukemia.
Gupta DG; Varma N; Abdulkadir SA; Sreedharanunni S; Sachdeva MUS; Naseem S; Bose P; Binota J; Malhotra P; Khadwal A; Trehan A; Varma S
Cancer; 2024 Mar; 130(5):713-726. PubMed ID: 37819686
[TBL] [Abstract] [Full Text] [Related]
9. Susceptibility of pediatric acute lymphoblastic leukemia to STAT3 inhibition depends on p53 induction.
Gasparoli L; Virely C; Tsakaneli A; Che N; Edwards D; Bartram J; Hubank M; Pal D; Heidenreich O; Martens JHA; De Boer J; Williams O
Haematologica; 2024 Apr; 109(4):1069-1081. PubMed ID: 37794795
[TBL] [Abstract] [Full Text] [Related]
10. [Leukemia Genotype Analysis of Children with Acute Lymphoblastic Leukemia in Yunnan Area].
Shi SL; Kui LY; Xia SM; Zhou BL; Li RJ; Jiang HC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Aug; 31(4):980-984. PubMed ID: 37551465
[TBL] [Abstract] [Full Text] [Related]
11. Causes of death and treatment-related mortality in newly diagnosed childhood acute lymphoblastic leukemia treatment with Chinese Children's Cancer Group study ALL-2015.
Liu K; Shao J; Cai J; Tang J; Shen S; Xu F; Ren Y; Zhang A; Tian X; Lu X; Hu S; Hu Q; Jiang H; Zhou F; Liang C; Leung AWK; Zhai X; Li C; Fang Y; Wang Z; Wen L; Yang H; Wang N; Jiang H
Ann Hematol; 2023 Dec; 102(12):3431-3444. PubMed ID: 37550503
[TBL] [Abstract] [Full Text] [Related]
12. Improved Outcome for ALL by Prolonging Therapy for
Pieters R; de Groot-Kruseman H; Fiocco M; Verwer F; Van Overveld M; Sonneveld E; van der Velden V; Beverloo HB; Bierings M; Dors N; de Haas V; Hoogerbrugge P; Van der Sluis I; Tissing W; Veening M; Boer J; Den Boer M
J Clin Oncol; 2023 Sep; 41(25):4130-4142. PubMed ID: 37459571
[TBL] [Abstract] [Full Text] [Related]
13. Characteristics of Molecular Genetic Mutations and Their Correlation with Prognosis in Adolescent and Adult Patients with Acute Lymphoblastic Leukemia.
Sun X; Liu X; Li Y; Shi X; Li Y; Tan R; Jiang Y; Sui X; Ge X; Xu H; Wang X; Fang X
Oncology; 2024; 102(1):85-98. PubMed ID: 37437551
[TBL] [Abstract] [Full Text] [Related]
14. Transcription factor abnormalities in B-ALL leukemogenesis and treatment.
Yin H; Wang J; Tan Y; Jiang M; Zhang H; Meng G
Trends Cancer; 2023 Oct; 9(10):855-870. PubMed ID: 37407363
[TBL] [Abstract] [Full Text] [Related]
15. Prognostic Significance of CD20 Expression in Children with Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic Leukemia.
Wang Y; Xue YJ; Jia YP; Zuo YX; Lu AD; Zhang LP
Acta Haematol; 2023; 146(5):349-357. PubMed ID: 37212472
[TBL] [Abstract] [Full Text] [Related]
16. Etiology of oncogenic fusions in 5,190 childhood cancers and its clinical and therapeutic implication.
Liu Y; Klein J; Bajpai R; Dong L; Tran Q; Kolekar P; Smith JL; Ries RE; Huang BJ; Wang YC; Alonzo TA; Tian L; Mulder HL; Shaw TI; Ma J; Walsh MP; Song G; Westover T; Autry RJ; Gout AM; Wheeler DA; Wan S; Wu G; Yang JJ; Evans WE; Loh M; Easton J; Zhang J; Klco JM; Meshinchi S; Brown PA; Pruett-Miller SM; Ma X
Nat Commun; 2023 Apr; 14(1):1739. PubMed ID: 37019972
[TBL] [Abstract] [Full Text] [Related]
17. Analysis of clinical and genomic profiles of therapy-related myeloid neoplasm in Korea.
Yun J; Song H; Kim SM; Kim S; Kwon SR; Lee YE; Jeong D; Park JH; Kwon S; Yun H; Lee DS
Hum Genomics; 2023 Feb; 17(1):13. PubMed ID: 36814285
[TBL] [Abstract] [Full Text] [Related]
18. Clinical, biological, and outcome features of P2RY8-CRLF2 and CRLF2 over-expression in pediatric B-cell precursor acute lymphoblastic leukemia according to the CCLG-ALL 2008 and 2018 protocol.
Wang Y; Li J; Xue TL; Tian S; Yue ZX; Liu SG; Gao C
Eur J Haematol; 2023 Jun; 110(6):669-679. PubMed ID: 36814093
[TBL] [Abstract] [Full Text] [Related]
19. The Landscape of Secondary Genetic Rearrangements in Pediatric Patients with B-Cell Acute Lymphoblastic Leukemia with t(12;21).
Kaczmarska A; Derebas J; Pinkosz M; Niedźwiecki M; Lejman M
Cells; 2023 Jan; 12(3):. PubMed ID: 36766699
[TBL] [Abstract] [Full Text] [Related]
20. Whole genome sequencing provides comprehensive genetic testing in childhood B-cell acute lymphoblastic leukaemia.
Ryan SL; Peden JF; Kingsbury Z; Schwab CJ; James T; Polonen P; Mijuskovic M; Becq J; Yim R; Cranston RE; Hedges DJ; Roberts KG; Mullighan CG; Vora A; Russell LJ; Bain R; Moorman AV; Bentley DR; Harrison CJ; Ross MT
Leukemia; 2023 Mar; 37(3):518-528. PubMed ID: 36658389
[TBL] [Abstract] [Full Text] [Related]
[Next]
